Bausch + Lomb (BLCO) - 2023 Q1 - Earnings Call Transcript

Moving now to the Surgical segment, first quarter revenue was $183 million, an increase of 9% on a constant currency basis. Implantables grew by 2% on a constant currency basis driven by strong performance in the highmargin premium IOL portfolio, which was up 32% in constant currency. We continue to see momentum in our investor franchise, which includes both the mono focal and toric IOLs. On a constant currency basis, the enVista franchise grew by 26% in the quarter. At a broader level, we continue to belie ...